A revenue-generating, small-cap Canadian pharmaceutical company

Revenue Projected at $150,000,000 by 2025

Free
Discussion Forum: Valeo Pharma Inc.
List Message View
Thread Message View
New Message
Author / Date /
Topic Title
Rating
Re
Last Post
AGORACOM-KE - Aug 02, 2022 07:00AM
Icon agoracom VALEO PHARMA ENTERS INTO AN AGREEMENT FOR OPHTHALMIC PRODUCTS, PrXIIDRA® AND PrSIMBRINZA®, IN CANADA

0
AGORACOM-KE
Aug 02, 2022 07:00AM
AGORACOM-KE - Mar 22, 2022 07:00AM
Icon agoracom Valeo Pharma Secures Additional Public Reimbursement For Redesca™, Enerzair® Breezhaler® And Atectura® Breezhaler®

1
run3donlineaz
Jul 30, 2022 04:34AM
AGORACOM-KE - May 09, 2022 11:00AM
Icon agoracom Valeo Pharma Inc. Opens the Market

2
run3donlineaz
Jul 30, 2022 04:33AM
AGORACOM-KE - Jun 14, 2022 05:55PM
Icon agoracom VALEO PHARMA REPORTS ITS SECOND QUARTER 2022 RESULTS AND HIGHLIGHTS

1
penny35598
Jul 08, 2022 05:15AM
AGORACOM-KE - Mar 17, 2022 07:00AM
Icon agoracom Valeo Pharma To Host First Quarter 2022 Results Conference Call / Webcast And Attend The 8Th Annual Alphanorth Capital Conference

1
penny5575
Jul 08, 2022 04:17AM
AGORACOM-KE - Jun 08, 2022 07:00AM
Icon agoracom VALEO PHARMA TO HOST SECOND QUARTER 2022 RESULTS CONFERENCE CALL / WEBCAST

0
AGORACOM-KE
Jun 08, 2022 07:00AM
AGORACOM-KE - Apr 28, 2022 08:51AM
Icon agoracom VALEO PHARMA ANNOUNCES RESULTS OF ANNUAL MEETING OF SHAREHOLDERS, APPOINTMENTS AND OPTIONS AND RSU GRANTS

0
AGORACOM-KE
Apr 28, 2022 08:51AM
AGORACOM-KE - Apr 25, 2022 07:00AM
Icon agoracom VALEO PHARMA TO PRESENT AT THE 2022 BLOOM BURTON & CO HEALTHCARE INVESTOR CONFERENCE

0
AGORACOM-KE
Apr 25, 2022 07:00AM
AGORACOM-KE - Apr 19, 2022 07:00AM
Icon agoracom Valeo Pharma Announces Listing Of Convertible Debentures On TSX

0
AGORACOM-KE
Apr 19, 2022 07:00AM
AGORACOM-KE - Mar 28, 2022 07:00AM
Icon agoracom Valeo Pharma Announces Listing To The Toronto Stock Exchange

0
AGORACOM-KE
Mar 28, 2022 07:00AM
masueigmr - Mar 24, 2022 11:21PM
Get Ready To Slither: 5 Things to Know Before Playing The New Game

0
masueigmr
Mar 24, 2022 11:21PM
AGORACOM-KE - Mar 24, 2022 05:41PM
Icon agoracom Valeo Pharma Reports Its First Quarter 2022 Results And Highlights

0
AGORACOM-KE
Mar 24, 2022 05:41PM
AGORACOM - Mar 24, 2022 05:41PM
Icon agoracom VALEO PHARMA REPORTS ITS FIRST QUARTER 2022 RESULTS AND HIGHLIGHTS

0
AGORACOM
Mar 24, 2022 05:41PM
AGORACOM-KE - Mar 22, 2022 02:43PM
Icon agoracom AGORACOM Small Cap 60: Valeo Pharma (VPH: CSE) (VPHIF: OTCQB) Asthma Drug Could Become Top Selling Product In Canada

0
AGORACOM-KE
Mar 22, 2022 02:43PM
AGORACOM-KE - Mar 21, 2022 11:20AM
Icon agoracom AGORACOM Small Cap 60: Valeo Pharma (VPH: CSE) (VPHIF: OTCQB) Experiencing Month Over Month Prescription Growth For Asthma Drugs

0
AGORACOM-KE
Mar 21, 2022 11:20AM
AGORACOM-KE - Mar 22, 2022 02:30PM
Icon agoracom AGORACOM Small Cap 60: Valeo Pharma (VPH: CSE) (VPHIF: OTCQB) Is Building The Capacity For Anticipated Growth

0
AGORACOM-KE
Mar 21, 2022 11:00AM
AGORACOM-KE - Mar 18, 2022 04:08PM
Icon agoracom AGORACOM Small Cap 60: Valeo Pharma (VPH: CSE) (VPHIF: OTCQB) Has Grown From 30 Employees To Over 100 In Last 12 Months

0
AGORACOM-KE
Mar 18, 2022 04:08PM
AGORACOM-KE - Mar 18, 2022 03:02PM
Icon agoracom AGORACOM Small Cap 60: Valeo Pharma (VPH: CSE) (VPHIF: OTCQB) Product Line, Reimbursements and Corporate Structure Are In Full Swing

0
AGORACOM-KE
Mar 18, 2022 03:02PM
AGORACOM-KE - Mar 17, 2022 05:15PM
Icon agoracom AGORACOM Small Cap 60: Valeo Pharma (VPH: CSE) (VPHIF: OTCQB) Q1 Results Coming Soon, Include Big Jump from Q4-21 Revenues

0
AGORACOM-KE
Mar 17, 2022 05:15PM
AGORACOM-KE - Mar 17, 2022 03:38PM
Icon agoracom AGORACOM Small Cap 60: Valeo Pharma (VPH: CSE) (VPHIF: OTCQB) $9M In H2-21 Revenue Indicative of Significant Growth

0
AGORACOM-KE
Mar 17, 2022 03:38PM
New Message